Burnham Asset Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
$243K Sell
3,292
-3,181
-49% -$220K 0.07% 178
2016
Q1
$421K Sell
6,473
-446
-6% -$30.3K 0.13% 150
2015
Q4
$533K Hold
6,919
0.15% 137
2015
Q3
$570K Sell
6,919
-335
-5% -$29.8K 0.15% 138
2015
Q2
$639K Hold
7,254
0.15% 143
2015
Q1
$641K Buy
7,254
+1,423
+24% +$126K 0.15% 146
2014
Q4
$484K Buy
5,831
+335
+6% +$27.8K 0.11% 164
2014
Q3
$464K Hold
5,496
0.1% 177
2014
Q2
$446K Hold
5,496
0.1% 186
2014
Q1
$419K Hold
5,496
0.1% 187
2013
Q4
$396K Hold
5,496
0.09% 188
2013
Q3
$378K Hold
5,496
0.09% 191
2013
Q2
$348K Buy
+5,496
New +$358K 0.09% 191

Other funds holding NVS

Burnham Asset Management's NVS Position: Q2 2016 in Review

Burnham Asset Management reduced its Novartis (NVS) stake by 49% in Q2 2016, selling an estimated $220K and leaving 3,292 shares worth $243K. The position accounts for 0.07% of the portfolio, ranked #178.

Burnham Asset Management first reported a position in NVS in Q2 2013 and has held it in 13 quarters since. The position peaked at $641K in Q1 2015. 878 funds tracked by Wall St. Rank hold NVS as of Q2 2016.

  • Burnham Asset Management held 3,292 shares of Novartis worth $243K as of Q2 2016.
  • Burnham Asset Management sold 3,181 Novartis shares in Q2 2016, an estimated $220K.
  • Novartis made up 0.07% of Burnham Asset Management's portfolio in Q2 2016, its #178 holding.
  • Burnham Asset Management first reported a position in Novartis in Q2 2013 and has held it in 13 quarters since.
  • Burnham Asset Management's Novartis position peaked at $641K in Q1 2015.
  • 878 funds tracked by Wall St. Rank held Novartis as of Q2 2016.

Based on Burnham Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.